European Archives - Page 345 of 1008 - European Medical Journal

Efficacy and Safety of Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).

EMJ Cardiology 10 [Supplement 5] 2022

Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).

First malaria vaccine granted WHO prequalification

The World Health Organization (WHO) has granted the first prequalification for a malaria vaccine to GSK’s Mosquirix in an important step toward immunising children against the disease.

EMJ announces partnership with the World Telehealth Initiative

EMJ is joining forces with the World Telehealth Initiative to support their mission to provide sustainable medical expertise through volunteer physicians…

Meet GOLD’s new catalyst – medical aficionado Juby Jacob-Nara

An exclusive version of our conversation Juby Jacob-Nara (Sanofi) about how former physicians can empower themselves to succeed in the pharmaceutical industry.

Latest updates in Advanced Systemic Mastocytosis from EHA 2022

Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.

COVID-19 and Antimicrobial Resistance

For decades, infectious disease and public health experts have recognised antimicrobial resistance (AMR) and resulting infections due to multidrug resistant organisms as a persistent and increasingly urgent threat to public health at the local, national, and global level.

Driving post-conference motivation in pharma: a how-to guide

How can pharma embrace post-conference momentum?

Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies

At the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress, held 9th–13th July, multiple oral and poster presentations were dedicated to gene therapy as a treatment for haemophilia A or B.

EMJ Hematology 10 [Supplement 5] 2022

This article covers multiple oral and poster presentations dedicated to gene therapy as a treatment for haemophilia A and B, which took place at the International Society on Thrombosis and Haemostasis (ISTH) Congress, 9th–13th July 2022.